On July 5, Novo Nordisk launched a phase III clinical trial of CagriSema injection in China, the purpose of which is to compare the safety and efficacy of CagriSema injection with semeglutide in obese and overweight patients in China
A licensed clinician will contact you within 24 hours of purchase to confirm eligibility and provide personalized guidance
Our role is to: Coordinate your evaluation with a licensed clinician Streamline the prescription and fulfillment process when treatment is appropriate Support you with clear timelines, shipping updates, and ongoing follow-up from our care team FAQ How much weight can I expect to lose in the first month
Changes to our bodies during and after childbirth occur for very specific reasons
This pattern differs from what typically occurs during caloric restriction and from what the Retatrutide data showed
Were feeling good, but what does that mean, data-wise